Epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A inhibits the growth of cholangiocarcinoma cells

Oncology Reports
Shigeki NakagawaHideo Baba

Abstract

Enhancer of zeste homolog 2 (EZH2) is involved in malignant transformation and the biological aggressiveness of several human malignancies. Growing evidence indicates that EZH2 may be an appropriate therapeutic target for malignancies, including cholangiocarcinoma. Recently, an S-adenosyl-L-homocysteine hydrolase inhibitor, 3-deazaneplanocin A (DZNep) was shown to deplete and inhibit EZH2. The aim of this study was to determine the effect of DZNep and the combination of gemcitabine and DZNep in cholangiocarcinoma cells. The effects of DZNep and its combination with gemcitabine were assessed in the cholangiocarcinoma cell lines RBE and TFK-1. DZNep depleted the cellular levels of EZH2 and inhibited the associated histone H3 lysine 27 trimethylation. DZNep treatment resulted in the inhibition of proliferation in the cholangiocarcinoma cell lines, and the combination of DZNep and gemcitabine showed synergistic inhibition of cell proliferation. DZNep induced apoptosis and G1 phase cell cycle arrest in cholangiocarcinoma cells, and the combination of DZNep and gemcitabine enhanced the induced apoptosis and G1 arrest when compared with gemcitabine alone. Inhibition of cell proliferation by DZNep was partially associated with upregula...Continue Reading

References

Jan 1, 1997·Gastroenterology·S K RobertsN F Larusso
May 1, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Gianfranco AlpiniNicholas F Larusso
Oct 11, 2002·Nature·Sooryanarayana VaramballyArul M Chinnaiyan
Sep 23, 2003·Proceedings of the National Academy of Sciences of the United States of America·Celina G KleerArul M Chinnaiyan
Jun 16, 2004·Current Opinion in Genetics & Development·Ru Cao, Yi Zhang
Dec 1, 2004·Annual Review of Genetics·Leonie Ringrose, Renato Paro
Dec 7, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ingeborg M BachmannLars A Akslen
Oct 25, 2006·Nature Reviews. Cancer·Anke Sparmann, Maarten van Lohuizen
Dec 14, 2006·Critical Reviews in Oncology/hematology·Melanie B Thomas
Feb 28, 2007·The American Journal of Gastroenterology·Yasser H ShaibManal M Hassan
Aug 11, 2007·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Tania M WelzelKatherine A McGlynn
Jul 16, 2008·International Journal of Cancer. Journal International Du Cancer·Nina WagenerFelix Hoppe-Seyler
Aug 30, 2008·Mutation Research·Jeffrey A Simon, Carol A Lange
Nov 5, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Andrei V OugolkovDaniel D Billadeau
Jun 11, 2009·Molecular Cancer Therapeutics·Tina Branscombe MirandaPeter A Jones
Oct 21, 2009·Liver International : Official Journal of the International Association for the Study of the Liver·Lian-Yuan TaoShang-Ming Zhang
Nov 26, 2009·Cancer Research·Mario-Luca SuvàIvan Stamenkovic
Jun 25, 2010·Human Pathology·Adam D TollAgnieszka K Witkiewicz
Mar 4, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Andrew Chase, Nicholas C P Cross
Feb 10, 2012·Journal of Hepato-biliary-pancreatic Sciences·Jason E Faris, Andrew X Zhu
Feb 11, 2012·Proceedings of the National Academy of Sciences of the United States of America·Michael T McCabeCaretha L Creasy
Aug 29, 2012·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Junko KikuchiHirotoshi Dosaka-Akita

❮ Previous
Next ❯

Citations

Jun 23, 2015·Current Opinion in Insect Science·Igor V Sharakhov, Maria V Sharakhova
Jun 19, 2018·Epigenetics : Official Journal of the DNA Methylation Society·Judit SymmankGeraldine Zimmer-Bensch
Mar 25, 2019·Liver International : Official Journal of the International Association for the Study of the Liver·Laura FouassierCédric Coulouarn
Oct 11, 2017·Nature Reviews. Clinical Oncology·Sumera RizviGregory J Gores
Nov 27, 2014·Expert Opinion on Therapeutic Targets·Christian MayrTobias Kiesslich
Jun 23, 2015·Neuropathology : Official Journal of the Japanese Society of Neuropathology·Suvendu PurkaitChitra Sarkar
Sep 30, 2015·Annals of Surgical Oncology·Ryuma TokunagaHideo Baba
Feb 7, 2018·Biology of Reproduction·Mariano Colón-CaraballoIdhaliz Flores
Dec 3, 2020·Annual Review of Pathology·Pedro M RodriguesJesus M Banales
Apr 24, 2021·Expert Review of Gastroenterology & Hepatology·Antonio CiglianoDiego F Calvisi
Sep 29, 2021·Expert Opinion on Investigational Drugs·Ranu S SinniahSreenivasa R Chandana
May 16, 2018·HPB : the Official Journal of the International Hepato Pancreato Biliary Association·Shigeki NakagawaHideo Baba

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis